ZARONTIN SYRUP
Google image searchProduct monograph
Active ingredient
ethosuximide, 250 MG/5 ML
DIN: 00023485
Dosage form(s): SYRUP
Route(s) of administration: ORAL
Schedule: Prescription
Company: SEARCHLIGHT PHARMA INC
Date: 11-OCT-2022
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AD — Succinimide derivatives (ATC, ATC/DDD)
- N03AD01 — ETHOSUXIMIDE (ATC/DDD)
Reference brand drug: Zarontin
Pharmaceutical standard: BP
